Search results for "Rheumatoid arthritis"
No associated increase in short-term malignancy risk with biologic therapy for rheumatoid arthritis
Biologic therapy does not appear to increase risk for malignancy in patients with rheumatoid arthritis, according to a new study.
https://immattersacp.org/weekly/archives/2012/09/11/5.htm
11 Sep 2012
MKSAP Quiz: 4-month history of skin lesions
This week's quiz asks readers to evaluate a 40-year-old woman for a 4-month history of symmetrically distributed, severely pruritic, grouped erosions on her elbows, knees, back, and buttocks.
https://immattersacp.org/weekly/archives/2012/09/11/3.htm
11 Sep 2012
MKSAP Quiz: Transfer prevented by low food intake, new bruising, gross hematuria
A 70-year-old malnourished man with a 4-year history of Alzheimer dementia is admitted to the intensive care unit from the emergency department for treatment of community-acquired pneumonia and impending respiratory failure. He is inattentive and confused and has a weak productive cough. What is the most likely diagnosis?
https://immattersacp.org/weekly/archives/2012/10/02/3.htm
2 Oct 2012
Taking a drink: what patients should know
Alcohol is associated with so many benefits and harms that it's hard to know where to start talking to patients about using it. One place might be alcohol misuse and abuse. Teach patients where they fall on the continuum of drinking behavior.
https://immattersacp.org/archives/2013/01/alcohol.htm
1 Jan 2013
Expanded approval on rivaroxaban, reassurance on dabigatran
This regulatory update covers an expanded indication for rivaroxaban and an announcement that bleeding rates do not appear to be higher with dabigatran than with warfarin.
https://immattersacp.org/archives/2013/01/fda.htm
1 Jan 2013
Start with bloodwork to diagnose anemia
Anemia is fairly common, but its many etiologies complicate diagnosis. It affects more than one in five black and Hispanic people, one in 10 seniors and one in five of those over the age of 85. Learn how to fine-tune the diagnosis to best help patients.
https://immattersacp.org/archives/2013/03/anemia.htm
1 Mar 2013
Early interventions overlooked in OA
Osteoarthritis has been somewhat neglected, according to a recently formed consortium that is advocating for more proactive diagnosis and intervention. Earlier screening and a less reactive approach might head off some of the worst of the difficulties and related treatment costs.
https://immattersacp.org/archives/2013/05/osteoarthritis.htm
1 May 2013
How to start and stop bisphosphonates
A new online tool and a few simple rules can inform internists how to start bisphosphonates and when to consider taking a drug holiday at the request of another physician, a dentist or even the patient.
https://immattersacp.org/archives/2013/06/bisphosphonates.htm
1 Jun 2013
DMARD triple therapy noninferior to, but less costly than, TNF inhibitor
In rheumatoid arthritis patients in whom first-line methotrexate therapy has failed, triple therapy with disease-modifying antirheumatic drugs (DMARDs) was noninferior to the tumor necrosis factor (TNF) inhibitor etanercept plus methotrexate, a study found.
https://immattersacp.org/weekly/archives/2013/06/18/2.htm
18 Jun 2013
Biological compared with conventional treatment may not improve work loss in early rheumatoid arthritis
Infliximab improved radiologic results but did not result in less work loss compared with conventional combination therapy in patients with early rheumatoid arthritis who did not respond sufficiently to methotrexate, a new study reports.
https://immattersacp.org/weekly/archives/2013/07/09/6.htm
9 Jul 2013